In our study, the Kaplan-Meier analysis indicated that EIF5A2 expression was associated with a poorer survival in patients with ESCC who underwent taxane-based chemotherapy after esophagectomy. This evidence concerns the gene EIF5A2 and esophageal squamous cell carcinoma.